To give tranexamic acid in reducing postpartum blood loss in vaginal deliveries

Effect of prophylactic tranexamic acid in reducing postpartum blood loss in vaginal deliveries at tertiary care centre; placebo controlled randomized clinical trial - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/066348

Enrollment

100

Registered

2024-04-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Tranexamic acid: Injection Tranexamic acid 1 gram slow direct intravenous infusion in 10 ml diluent over 10 minutes single dose Control Intervention1: Normal saline: Injection norma

Eligibility

Inclusion criteria

Inclusion criteria: prmigravida or secondary gravida 37 to 42 weeks of gestation admitted in active labour normotensive cephalic presentation

Exclusion criteria

Exclusion criteria: All other patients not fulfilling the inclusion criteria

Design outcomes

Primary

Measure	Time frame
To quantify the mean 2hour postpartum blood lossTimepoint: from delivery to 2 hour postpartum	—

Secondary

Measure	Time frame
To see if any other intervention needed after delivery & to compare the need of blood transfusion & to see the potential adverse effects of tranexamic acid. Timepoint: from delivery till patient discharged.	—

Countries

India

Contacts

Public ContactDr Seema

DR SN MEDICAL COLLEGE

pummyia@gmail.com9079320629

Outcome results